|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002965,
umls-concept:C0016011,
umls-concept:C0021701,
umls-concept:C0031928,
umls-concept:C0034656,
umls-concept:C0205191,
umls-concept:C0332206,
umls-concept:C0522523,
umls-concept:C0529558,
umls-concept:C1416485,
umls-concept:C1522318,
umls-concept:C1948041
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-8-14
|
|
pubmed:abstractText |
Clinical studies have demonstrated the efficacy of intravenous administration of agents that block platelet glycoprotein IIb/IIIa receptors in the setting of percutaneous coronary revascularization. Although the optimal duration of treatment has not been determined, more prolonged receptor blockade has been associated with increased efficacy. Orally active glycoprotein IIb/IIIa receptor antagonists may be advantageous and required for chronic therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
pubmed-author:AndersR JRJ,
pubmed-author:BurnsD MDM,
pubmed-author:CourC ACA,
pubmed-author:DeFrancoA CAC,
pubmed-author:EllisS GSG,
pubmed-author:Kottke-MarchantKK,
pubmed-author:LowrieMM,
pubmed-author:MillerD PDP,
pubmed-author:MoliternoD JDJ,
pubmed-author:RaymondR ERE,
pubmed-author:SimpfendorferCC,
pubmed-author:SuttonJ MJM,
pubmed-author:TopolE JEJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
76-81
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9236420-Adult,
pubmed-meshheading:9236420-Aged,
pubmed-meshheading:9236420-Angina, Unstable,
pubmed-meshheading:9236420-Angioplasty, Balloon, Coronary,
pubmed-meshheading:9236420-Aspirin,
pubmed-meshheading:9236420-Benzamidines,
pubmed-meshheading:9236420-Coronary Artery Bypass,
pubmed-meshheading:9236420-Diabetes Mellitus, Type 1,
pubmed-meshheading:9236420-Female,
pubmed-meshheading:9236420-Follow-Up Studies,
pubmed-meshheading:9236420-Hemorrhage,
pubmed-meshheading:9236420-Humans,
pubmed-meshheading:9236420-Male,
pubmed-meshheading:9236420-Middle Aged,
pubmed-meshheading:9236420-Pilot Projects,
pubmed-meshheading:9236420-Platelet Aggregation,
pubmed-meshheading:9236420-Platelet Aggregation Inhibitors,
pubmed-meshheading:9236420-Platelet Function Tests,
pubmed-meshheading:9236420-Platelet Glycoprotein GPIIb-IIIa Complex
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
|
|
pubmed:affiliation |
Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
